Identification of Aluminium Fractions in Serum Using the Techniques of High Performance Liquid Chromatography, Ultrafiltration and Zeeman Atomic Absorption Spectrometry1

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 3, 1997, Pages 215-222

  Röllin, Haiina B ^a   Nogueira, Claudina M C A ^a  

^a National Centre for Occupational Health   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; TRANSFERRIN;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD ANALYSIS; BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; GEL FILTRATION; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METAL BINDING; MOLECULAR WEIGHT; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BINDING; ULTRAFILTRATION;

ALUMINUM; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MOLECULAR WEIGHT; OCCUPATIONAL EXPOSURE; SPECTROPHOTOMETRY, ATOMIC; ULTRAFILTRATION;

EID: 0030892362     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.3.215     Document Type: Article

References (25)

1. Alfrey AC, LeGrende GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminium intoxication. N Engl J Med 1976; 294: 184-188.
2. Wills MR, Savory J. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet 1983; 11: 29-34.
3. Crapper DR, Quittkat S, Krishnan SS, Dalton AJ, DeBoni U. Intranuclear aluminium content in Alzheimer’s disease, dialysis encephalopathy, and experimental aluminium encephalopathy. Acta Neuropathol 1980; 54: 19-24.
4. Rifat SL, Eastwood MR, Crapper McLachlan DR, Corey PN. Effect of exposure of miners to aluminium powder. Lancet 1990; 336: 1162-5.
5. White DM, Longstreth WT Jr, Rosenstock L, Claypoole KHL, Brodkin CA, Towns BD. Neurological syndrome in 25 workers from an aluminium smelting plant. Arch Intern Med 1992; 152: 1443-8.
6. Gitelman HJ, Alderman FR, Kurs-Lasky M, Rockette HE. Serum and urinary levels of workers in the aluminium industry. Ann Occup Hyg 1995; 29: 181-191.
7. Rollin HB, Theodorou P, Cantrell AC. Biological indicators of exposure to total and respirable aluminium dust fractions in a primary aluminium smelter. Occup Env Med 1996; 53: 417-421.
8. Venturini M, Berthon G. Aluminium speciation studies in biological fluids. Part 2. Quantitative investigation of aluminium-citrate complexes and appraisal of their potential significance in vivo. J Inorg Biochem 1989; 37: 69-90.
9. Day JP, Barker J, Evans LJA, Perks J, Seabright PJ, Acrill P, et al. Aluminium absorption studied by 26Al tracer. Lancet 1991; 337: 1345.
10. Morris CM, Candy JM, Oakley AE, Taylor GA, Mountfort S, Bishop H, et al. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J Neurol Sci 1989; 94: 295.
11. Fatemi SJA, Kadir FHA, Moore GR. Aluminium transport in blood serum. Binding of aluminium by human transferrin in presence of human albumin and citrate. Biochem J 1991; 280: 527-532.
12. Fatemi SJA, Williamson DJ, Moore GR. 27Al NMR investigation of Al3+ binding to small carboxylic acids and the proteins albumin and transferrin. J Inorg Biochem 1992; 46: 35-40.
13. Marques H. Kinetics of the release of aluminium from human serum dialuminium transferrin to citrate. J Inorg Biochem 1991; 41: 187-193.
14. Trapp GA. Plasma aluminium is bound to transferrin. Life Sciences 1983; 33: 311-316.
15. Bertholf RL, Wills MR, Savory J. Quantitative study of aluminium binding to human serum albumin and transferrin by a chelex competitive binding assay. Biochem Biophys Res Comm 1984; 125: 1020-4.
16. Favarato M, Mizzen CA, McLachlan DR. Resolution of serum aluminium-binding proteins by size-exclusion chromatography: identification of a new carrier of aluminium in human serum. J Chromatogr 1992; 576: 271-285.
17. Perez Parajon J, Blanco Gonzalez E, Cannata JB, Sanz Medel A. A critical appraisal of the speciation of aluminum by ultrafiltration. Trace Elem Med 1989; 6: 41-46.
18. Van Ginkel MF, Van der Voet GB, Van Eijk HG, Wolff FA. Aluminium binding to serum constituents: a role for transferrin and for citrate. J Clin Chem Clin Biochem 1990; 28: 459-463.
19. King SW, Savory J, Wills MR. Aluminium distribution in serum following haemodialysis. Ann Clin Lab Sci 1982; 12: 143-149.
20. Wrobel K, Blanco Gonzalez E, Sanz Medel A. Ultrafiltrable aluminium in normal and uraemic sera: influence of desferrioxamine therapy. Trace Elem Med 1993; 10: 97-103.
21. Van Landeghem GF, D'Haese PC, Lamberts LV, De Broe ME. Quantitative HPLC/ETAAS hybrid method with an on-line metal scavenger for studying the protein binding and speciation of aluminium and iron. Anal Chem 1994; 66: 216-222.
22. Wrobel K, Blanco Gonzalez E, Wrobel K, Sanz Medel A. Aluminium and silicon speciation in human serum by ion-exchange high-performance liquid chromatography-electrothermal atomic absorption spectrometry and gel electrophoresis. Analyst 1995; 120: 809-815.
23. Bradley C, Leung FY. Aluminium determined in plasma and urine by atomic absorption spectroscopy with a transversely heated graphite atomizer furnace. Clin Chem 1994; 40: 431-434.
24. Favarato M, Mizzen CA, Sutherland MK, Krishnan B, Kruck TPA, Crapper McLachlan DR. Aluminium-binding serum proteins: desferrioxamine alters serum aluminium speciation. Clin Chim Acta 1992; 207: 41-55.
25. Martin RB. Aluminium speciation in biology. In: Wiley J & Sons, editors. Aluminium in biology and medicine. Ciba Foundation Symposium 169, 1992:5-25.